TY - JOUR
KW - Substance Abusers -- Iran
KW - Combined Modality Therapy
KW - Cognitive Therapy -- Methods
KW - Antipsychotic Agents -- therapeutic use
KW - Amphetamine
KW - Substance Abuse -- Prevention and Control
KW - Human
KW - Systematic Review
KW - Treatment Outcomes
KW - Iran
KW - MEDLINE
KW - PubMed
KW - Cochrane Library
KW - CINAHL Database
KW - Embase
KW - Psycinfo
KW - Risperidone -- Therapeutic Use
KW - Aripiprazole -- Therapeutic Use
KW - Topiramate -- Therapeutic Use
KW - Methylphenidate -- Therapeutic Use
KW - Buprenorphine -- Therapeutic Use
KW - Depression -- Prevention and Control
KW - Psychotic Disorders -- Prevention and Control
KW - Craving -- Prevention and Control
KW - Substance Withdrawal Syndrome -- Prevention and Control
KW - Methamphetamine
KW - Haloperidol -- Therapeutic Use
KW - Riluzole -- Therapeutic Use
KW - polypharmacy
KW - treatment duration
KW - Severity of Illness
KW - Mental Health
KW - Motivation
AU - Mansour Khoramizadeh
AU - Mohammad Effatpanah
AU - Alireza Mostaghimi
AU - Mehdi Rezaei
AU - Alireza Mahjoub
AU - Sara Shishehgar
A1 - 
AD - Research Institute for Islamic and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran; School of Medicine, Ziaeian Hospital, Tehran University of Medical Sciences, Tehran, Iran; Student Research Center of International Campus, Tehran University of Medical Sciences, Tehran, Iran; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; Women's and New Born Health Department, Westmead Hospital, Sydney, Australia
BT - DARU
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - , <Blank>
DO - 10.1007/s40199-019-00282-3
JF - DARU
LA - English
M1 - Journal Article
PB - Springer Nature
PP - , <Blank>
PY - 2019
SN - 1560-8115
SP - 743
EP - 753
EP - 
T1 - Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern
T2 - DARU
TI - Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1007/s40199-019-00282-3
VL - 27
VO - 1560-8115
Y1 - 2019
Y2 - 06/21
ER -